Annual Retained Earnings
-$309.21 M
-$117.67 M-61.44%
31 December 2023
Summary:
Athira Pharma annual retained earnings is currently -$309.21 million, with the most recent change of -$117.67 million (-61.44%) on 31 December 2023. During the last 3 years, it has fallen by -$268.16 million (-653.39%). ATHA annual retained earnings is now -1841.52% below its all-time high of -$15.93 million, reached on 31 December 2018.ATHA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$391.14 M
-$28.74 M-7.93%
30 September 2024
Summary:
Athira Pharma quarterly retained earnings is currently -$391.14 million, with the most recent change of -$28.74 million (-7.93%) on 30 September 2024. Over the past year, it has dropped by -$109.22 million (-38.74%). ATHA quarterly retained earnings is now -1754.90% below its all-time high of -$21.09 million, reached on 31 December 2019.ATHA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -61.4% | -38.7% |
3 y3 years | -653.4% | -391.7% |
5 y5 years | -1841.5% | - |
ATHA Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -653.4% | at low | -391.7% | at low |
5 y | 5 years | -1841.5% | at low | -1754.9% | at low |
alltime | all time | -1841.5% | at low | -1754.9% | at low |
Athira Pharma Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$391.14 M(+7.9%) |
June 2024 | - | -$362.40 M(+8.0%) |
Mar 2024 | - | -$335.54 M(+8.5%) |
Dec 2023 | -$309.21 M(+61.4%) | -$309.21 M(+9.7%) |
Sept 2023 | - | -$281.92 M(+13.2%) |
June 2023 | - | -$248.95 M(+13.5%) |
Mar 2023 | - | -$219.35 M(+14.5%) |
Dec 2022 | -$191.53 M | -$191.53 M(+18.7%) |
Sept 2022 | - | -$161.40 M(+14.3%) |
June 2022 | - | -$141.21 M(+20.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -$116.88 M(+21.9%) |
Dec 2021 | -$95.89 M(+133.7%) | -$95.89 M(+20.5%) |
Sept 2021 | - | -$79.56 M(+24.5%) |
June 2021 | - | -$63.88 M(+28.0%) |
Mar 2021 | - | -$49.91 M(+21.6%) |
Dec 2020 | -$41.04 M(+94.6%) | -$41.04 M(+23.1%) |
Sept 2020 | - | -$33.34 M(+31.6%) |
June 2020 | - | -$25.34 M(+20.2%) |
Dec 2019 | -$21.09 M(+32.4%) | -$21.09 M |
Dec 2018 | -$15.93 M | - |
FAQ
- What is Athira Pharma annual retained earnings?
- What is the all time high annual retained earnings for Athira Pharma?
- What is Athira Pharma annual retained earnings year-on-year change?
- What is Athira Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Athira Pharma?
- What is Athira Pharma quarterly retained earnings year-on-year change?
What is Athira Pharma annual retained earnings?
The current annual retained earnings of ATHA is -$309.21 M
What is the all time high annual retained earnings for Athira Pharma?
Athira Pharma all-time high annual retained earnings is -$15.93 M
What is Athira Pharma annual retained earnings year-on-year change?
Over the past year, ATHA annual retained earnings has changed by -$117.67 M (-61.44%)
What is Athira Pharma quarterly retained earnings?
The current quarterly retained earnings of ATHA is -$391.14 M
What is the all time high quarterly retained earnings for Athira Pharma?
Athira Pharma all-time high quarterly retained earnings is -$21.09 M
What is Athira Pharma quarterly retained earnings year-on-year change?
Over the past year, ATHA quarterly retained earnings has changed by -$109.22 M (-38.74%)